The QT line is what a 2.5 or 5 mg Levitra script actually opens with
Write the strongest-pill claim. Open the Levitra label. The QT caution stays. The trophy goes.
Men still walk in asking for the strongest tablet in the class. The US label does not offer that prize. It opens with the same nitrate prohibition every PDE5 inhibitor carries, then a thorough-QT finding: vardenafil lengthens the interval a little, reproducibly, in a dedicated study. That is the line Priya writes first when a man asks for prescription pills by brand.
A 2.5 or 5 mg start is not a meek marketing choice. Men over 65, men with moderate hepatic impairment, and men on strong CYP3A4 inhibitors see higher plasma levels at any swallowed milligram. The label answers with a lower first tablet - 5 mg for age or liver, 2.5 mg in the ritonavir and indinavir row. Calling that 'weak' is the rumor. Calling it exposure control is the file.
Bayer built a sildenafil-like scaffold with higher in-vitro PDE5 potency. That number sold early ads. Head-to-head intercourse success sat in the same band as the older drug. If a man wants less PDE6 visual tint, vardenafil can earn a switch. If he wants a potency trophy, the label will not sign it. The origins paper trail sits in Wuppertal to Levitra 2.5 or 5 mg.
Nitrates still kill the script - that claim does not get a carve-out
Nitroglycerin spray in the same pocket as a Levitra blister is the claim that gets people hurt. Both drugs raise cyclic GMP. Together they can drop blood pressure into a range the heart cannot use. Spray, patch, tablet, isosorbide, amyl nitrite 'poppers' - the label treats them as one family. There is no 'small nitrate' exception.
Emergency staff need the name if chest pain starts after a dose. Some men hide the ED tablet. That delay is how a treatable angina night becomes a collapsed-pressure night. Priya's strike is blunt: if a nitrate is on the list, vardenafil is not. Another PDE5 inhibitor will not save the combination either.
Alpha-blockers are a different, smaller problem - additive hypotension, not the same absolute ban. Separate the clock, start at the low tablet, and name the prostate drug out loud. Grapefruit juice is a nudge, not a crisis, but a large glass near dosing is a sloppy way to raise levels.
Why 2.5 or 5 mg is a start, not a trophy milligram
| Situation | Labelled move | Why the milligram changes |
|---|---|---|
| Usual on-demand start | 10 mg about 1 h before | No age, liver, or strong CYP3A4 flag |
| Effective range | 5-20 mg, once / 24 h | Titrate to rigidity and side effects |
| Age over 65 or moderate hepatic impairment | Start 5 mg | Same tablet, higher exposure |
| Ketoconazole, itraconazole, clarithromycin | Cap 2.5-5 mg | CYP3A4 inhibition |
| Ritonavir or indinavir | Max 2.5 mg / 24 h | Potent CYP3A4 block |
| Staxyn ODT | Fixed 10 mg | Not interchangeable with swallowed tablets |
A 2.5 mg tablet is a CYP3A4-and-age tool, not the 'real' Levitra hiding behind 20 mg ads. Usual on-demand start for a man without those flags is 10 mg about an hour before sex, then 5-20 mg by response, once in 24 hours. This desk locks the SERP conversation on 2.5 or 5 mg because that is the labelled first move when exposure climbs.
Titration is a conversation, not a weekend experiment. Jumping to 20 mg after one greasy dinner and no stimulation teaches the wrong lesson. Three quieter nights - lighter meal, actual arousal, the prescribed milligram - tell you more than a single disappointed hour.
Staxyn, the orally disintegrating 10 mg tablet, is a convenience form. It is not milligram-equivalent to a swallowed 10 mg film-coated tablet. Men who need a 5 mg start should not be handed the melt as a swap. The timing note is in fat, grapefruit, and a 2.5 or 5 mg start.
A greasy plate moves the clock more than a brand name
Steak night is the quiet reason a 'failed' 10 mg looks like a dud. High-fat meals delay and blunt the peak. Fasting, plasma usually crests in 30-60 minutes. Absolute bioavailability is only about 15% after first-pass loss - the approved milligrams already assume that waste. Adding a heavy dinner on top makes the peak later and lower.
Half-life sits around 4-5 hours. Useful window is a few hours, not a weekend. Men who want a Saturday-to-Sunday span are asking for tadalafil's clock, not vardenafil's. Protein binding is high, near 95%. Elimination is mostly fecal. The kidney is a minor route, which is why liver and age move the start more than a modest creatinine bump.
CYP3A4 does the main metabolism, with a smaller CYP2C share. That is why the inhibitor table is not trivia. A man on ritonavir who swallows a leftover 20 mg from a friend is not 'trying a higher dose.' He is stacking exposure the label already capped at 2.5 mg.
What a Levitra 2.5 mg x 10 fill actually quotes
| Pharmacy | Fill | Published band | What this row is doing |
|---|---|---|---|
| Costco Pharmacy | 2.5 mg x 10 | $90-$130 warehouse / coupon | Membership warehouse; 10-count inferred from the $289 30-count coupon band |
| Kroger Pharmacy | 2.5 mg x 10 | $300-$450 cash sticker | Grocery cash can jump; one WebMDRx ZIP printed a four-figure 30-count coupon |
| Sam's Club Pharmacy | 2.5 mg x 10 | $90-$140 warehouse | Warehouse cash usually under chain sticker; confirm the 2.5 mg SKU, not a 20 mg quote |
| Target (CVS Pharmacy) | 2.5 mg x 10 | $95-$130 coupon | CVS-run counter; 30-count CVS coupons near $286 imply a three-figure 10-count |
Ten 2.5 mg tablets are a thin listing. Coupon boards print 30-count 2.5 mg far more often than a 10-count, and the cash sticker on the low milligram can look absurd next to a 20 mg ten-pack. That is a wholesale-and-demand quirk, not proof the small tablet is 'stronger.' Priya files the quote after the QT and nitrate lines, never before.
GoodRx's 6 July 2026 table printed $1,100.46 average retail and $289.61 coupon for generic vardenafil 2.5 mg x 30. Drugs.com cash stickers for the same 30-count sat near $1,174.64-$1,240.84. A 10-count is rarely posted as its own SKU, so the cells below are warehouse-versus-sticker ranges, not a invented single price. Sam's Club's $32.78 GoodRx print that week was 20 mg x 10 - a different strength, left out of the cells on purpose.
Health Fact Line does not sell pills. A licensed US pharmacy fills a prescription after a clinician has already walked the QT and nitrate questions. Coupon sites stay in the caption. Each row links that chain's own pharmacy page.
Ritonavir, ketoconazole, and the rhythm drugs that steal the slot
| Interacting agent | Label concern | Filed step |
|---|---|---|
| Any nitrate | Life-threatening hypotension | Absolute ban - never combine |
| QT-prolonging antiarrhythmics | Additive QT stretch | Prefer another PDE5 inhibitor |
| Strong CYP3A4 inhibitors | Raised vardenafil levels | Apply the 2.5 or 5 mg caps |
| Alpha-blockers | Added blood-pressure drop | Separate timing; start low |
| Large grapefruit juice | Mild CYP3A4 nudge | Skip the big glass near dosing |
Ritonavir does not negotiate with vardenafil. Indinavir neither. Those two force a 2.5 mg ceiling in 24 hours. Ketoconazole, itraconazole, and clarithromycin sit in the 2.5-5 mg cap row. The claim 'I always take 20 mg' gets struck the moment a strong CYP3A4 inhibitor is on the list.
QT-prolonging antiarrhythmics - quinidine, procainamide, amiodarone, sotalol - are the other steal. Additive interval stretch is the concern. Priya would rather move that man to another PDE5 inhibitor than argue about a modest, real signal. Long-QT syndrome is the same walk-away.
The evidence note that keeps the QT row honest is in Levitra 2.5-5 mg reviews vs the QT row. Efficacy trials were unsurprising: questionnaires and successful intercourse counts beat placebo, including diabetes and post-prostate cohorts, in the same band as sildenafil. The thorough-QT study is the outlier that still belongs on the blotter.
Staxyn is a tongue melt, not a swallowed-tablet swap
Sildenafil opens the oral ED market and starts the follow-on PDE5 race.
Bayer builds vardenafil, structurally close to sildenafil, louder in the test tube.
FDA approves Levitra the same year tadalafil arrives.
Staxyn ODT is cleared to dissolve on the tongue - fixed 10 mg, not a swallowed swap.
US patent protection lapses; generic vardenafil reaches ordinary counters.
The melt-on-tongue tablet is a convenience story from 2010, not a faster or stronger clinical entity. It dissolves without water. The labelled strength is fixed at 10 mg. Men who need the 5 mg start - age, liver - should not receive Staxyn as a 'same class, close enough' substitute.
US approval for swallowed Levitra was 2003, the same year tadalafil arrived, sandwiched between Viagra mindshare and Cialis duration. Generic vardenafil followed the 2018 patent lapse. Brand nostalgia does not change the QT line or the nitrate ban.
A licensed generic from a real pharmacy is the same active salt. Pills bought from a cart that will not name a pharmacist are a different problem - wrong milligram, wrong ingredient, no QT conversation at all.
How Priya files Levitra against Viagra and Cialis
| Property | Sildenafil (Viagra) | Tadalafil (Cialis) | Vardenafil (Levitra) |
|---|---|---|---|
| Class | PDE5 inhibitor | PDE5 inhibitor | PDE5 inhibitor |
| Onset | ~30-60 min | ~30-45 min | ~30-60 min |
| Half-life | ~4 h | ~17.5 h | ~4-5 h |
| Duration | ~4-6 h | up to ~36 h | ~4-6 h |
| Food | Fatty meal delays | Minimal | Fatty meal delays |
| Visual tint | More common (PDE6) | Uncommon | Less common |
| QT signal | No dedicated caution | No dedicated caution | Modest prolongation |
| Nitrates | Contraindicated | Contraindicated | Contraindicated |
Priya does not rank the three PDE5 inhibitors by 'strength.' She files duration, food, vision, and the QT row. Sildenafil and vardenafil share a short on-demand clock. Tadalafil keeps a much longer half-life and a daily option the other two lack. Food delays the two short-acting tablets. Visual tint is more a sildenafil / PDE6 complaint. Only vardenafil carries the modest QT caution in everyday counseling.
The nitrate column is identical. Anyone selling a 'safer with nitro' story is inventing a label. BPH and PAH approvals belong to tadalafil, not to Levitra. A man who wants those extra labelled jobs is in the wrong monograph.
Preference studies often favored tadalafil's lifestyle span, not raw rigidity. That is a schedule choice. Edge cases for vardenafil: less blue-vision bother, a short window the man actually wants, and a clean rhythm-drug history.
Blue tint versus a QT row - pick the trade you can live with
Blue vision is a PDE6 complaint more often laid at sildenafil's door. Vardenafil is more PDE5-selective, so fewer men report the tint. That is a real switch reason. It is not a reason to ignore headache, flush, stuffy nose, dyspepsia, or a light head - those are vasodilation doing its job, usually brief.
Priapism past four hours is an emergency. Sudden vision or hearing loss is the same-day stop. Sex is exertion. Unstable angina, a recent infarct or stroke, an uncontrolled arrhythmia, or severe heart failure is a fitness-for-sex question before it is a pill question.
Common effects do not need a dramatic story. Hydration, a lower tablet, and acetaminophen if the man's other drugs allow it will settle most headaches. Persistent severe pain is a reason to change molecule, not to 'push through' a 20 mg.
Who should walk past this molecule
Unstable angina is a sex-fitness hold, not a vardenafil-specific mystery. Recent myocardial infarction, recent stroke, uncontrolled arrhythmia, and severe heart failure sit in the same pause. The tablet does not make those nights safer.
Severe hepatic disease is a walk-away. Moderate impairment starts at 5 mg with a lower ceiling. Severe renal failure and dialysis are under-studied; caution, not casual 20 mg. Age over 65 starts at 5 mg and weighs the QT row harder when rhythm drugs are already in the box.
This is a men's ED drug on the US label. It does not treat BPH. It does not treat pulmonary arterial hypertension. Anyone shopping it for those jobs is reading the wrong carton.
The line that stays on the blotter
File the usable line: on-demand vardenafil on a few-hour clock, 2.5 or 5 mg first when age, liver, or a CYP3A4 inhibitor raises the level, QT caution named out loud, nitrates never. Not a potency upgrade over sildenafil. Not a daily tablet.
Carry the two strikes out of the room. Never with nitrates. Prefer another PDE5 inhibitor when the QT row is already crowded. The rest is ordinary counseling - food, stimulation, once in 24 hours.
History and numbers live in the approval path and the evidence review. A warehouse quote for 2.5 mg x 10 is a price check after those lines, not a reason to skip them.